Patents by Inventor Michael H. Dosik

Michael H. Dosik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100317010
    Abstract: ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5? untranslated region, and a novel Alu, Alukwd. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
    Type: Application
    Filed: May 17, 2010
    Publication date: December 16, 2010
    Inventors: Mark H. Kaplan, Michael H. Dosik, Xue-Ping Wang
  • Patent number: 7718783
    Abstract: ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5? untranslated region, and a novel Alu, Alukwd. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: May 18, 2010
    Inventors: Mark H. Kaplan, Michael H. Dosik, Xue-Ping Wang
  • Publication number: 20080261216
    Abstract: The present invention relates to compositions and methods for cancer diagnosis and therapy, including but not limited to, cancer markers. In particular, the present invention relates to HERV-K(HML-2) target titers as diagnostic markers, and HERV-K(HML-2) therapeutic targets for HIV-related cancers, and other cancers.
    Type: Application
    Filed: September 10, 2007
    Publication date: October 23, 2008
    Applicant: The Regents of the University of Michigan
    Inventors: David Markovitz, Rafael Contreras-Galindo, Mark H. Kaplan, Michael H. Dosik